MMP-9 microsatellite polymorphism and multiple sclerosis

J Neuroimmunol. 2004 Jul;152(1-2):147-53. doi: 10.1016/j.jneuroim.2004.03.009.

Abstract

A polymorphism (PM) in the microsatellite of the promoter region of matrix metalloproteinase 9 (MMP-9), modulating its expression, could play a role in susceptibility to multiple sclerosis (MS). MMP-9 PM was determined in 95 patients with MS (MS Group) and 95 age- and sex-matched controls (Control Group). Comparison of allelic frequencies showed that a higher number of CA repeats characterized the MS group (P<0.0001) and prevalence of carriers of > or =22 CA repeats was higher in the MS than in the Control Group (OR 3.4, 95% CI: 1.7-6.8, P<0.0001). An earlier age at disease onset was a characteristic of patients with >22 CA repeats (33+/-10 vs. 28+/-10, P=0.027). No differences were found in the main MRI parameters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Brain / diagnostic imaging
  • Brain / pathology*
  • Female
  • Genetic Markers
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging
  • Male
  • Matrix Metalloproteinase 9 / genetics*
  • Microsatellite Repeats
  • Middle Aged
  • Multiple Sclerosis / diagnostic imaging
  • Multiple Sclerosis / genetics*
  • Multiple Sclerosis / pathology*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic
  • Radiography
  • Risk Factors

Substances

  • Genetic Markers
  • Matrix Metalloproteinase 9